bimatoprost
Pre-clinical- Indications
- Glaucoma
Company intelligence / Profile preview
Spyglass Solutions
Aliso Viejo, California, United Statesspyglasspharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Preclinical
01
Overview
SpyGlass Pharma’s IOL-mounted drug delivery platform is designed to provide up to three years of sustained bimatoprost release for glaucoma patients undergoing cataract surgery. In an 18-month first-in-human study, the device demonstrated statistically significant improvements in visual outcomes and intraocular pressure reduction compared to baseline. The company is advancing through two pivotal Phase 3 trials with plans to present further long-term data at major ophthalmology meetings.
- Therapeutic areas
- Ophthalmology
- Modalities
- DeviceSmall molecule (bimatoprost)Drug/device combination product
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025; key investors include Sands Capital, Gilde Healthcare, NEA, RA Capital, Vensana Capital, Samsara BioCapital, Vertex Ventures HC
Beyond the preview
Go deeper on Spyglass Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Spyglass Solutions.